SCHEMBL2596935

SCHEMBL2596935

Cc1cnc(Cl)cc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29451611 1.00
SCHEMBL28602528 0.85
SCHEMBL31729551 0.81
SCHEMBL535618 0.81
Ammonia Solution, Strong SCHEMBL25341066 0.79 UHRF1 (0.58)
SCHEMBL29479539 0.77
SCHEMBL191846 0.77
SCHEMBL1644729 0.77
SCHEMBL30669490 0.77
SCHEMBL6307027 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118580179-A Preparation method of 2-chloro-4-cyclohexyl-5-methylpyridine 上海鲲博玖瑞医药科技发展有限公司 2024-09-03 CN claimed
CN-117753351-A Constant temperature and constant pressure preparation device for 2-chloro-4-amino-5-methylpyridine organic compound 南京康德祥医药科技有限公司 2024-03-26 CN claimed
CN-117069651-A Continuous synthesis method of 2-chloro-4-amino-5-methylpyridine 福建桦智工程技术有限公司 2023-11-17 CN claimed
CN-114957250-B N- (9H-pyridine [2,3-b ] indol-4-yl) aryl carboxamide derivative and preparation method and application thereof 中国人民解放军北部战区总医院 2023-05-09 CN claimed
CN-115991670-A Preparation method of 4-bromo-6-chloronicotinic acid 山西永津集团有限公司 2023-04-21 CN claimed
CN-115894354-A Synthetic method of non-neferide ketone intermediate 4-amino-5-methylpyridine-2-alcohol 中国药科大学 2023-04-04 CN claimed
CN-115340492-A Preparation method of 2-hydroxy-4-amino-5-methylpyridine 武汉海特生物创新医药研究有限公司 2022-11-15 CN claimed
CN-114957250-A N- (9H-pyridine [2,3-b ] indole-4-yl) aryl formamide derivatives, and preparation method and application thereof 中国人民解放军北部战区总医院 2022-08-30 CN claimed
CN-114656400-A Preparation method of key intermediate of non-neferitone 浙江科聚生物医药有限公司 2022-06-24 CN claimed
CN-103193704-A 2-hydroxy-4-amino-5-methylpyridine heterocyclic compound SICHUAN BERARE BIOLOG MEDICAL CO LTD 2013-07-10 CN claimed
EP-4735431-A2 MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. (US) 2026-05-06 EP disclosed
US-12616696-B2 Crystalline forms of (p)-3-chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2′-(2-(2-hydroxypropan-2-yl)pyrimidin-4-yl)-5′,6-dimethyl-2h-[1,4′-bipyridin]-2-one ACLARIS THERAPEUTICS, INC. (US) 2026-05-05 US disclosed
CN-117069651-B Continuous synthesis method of 2-chloro-4-amino-5-methylpyridine 福建桦智工程技术有限公司 2026-04-24 CN disclosed
CN-117069651-B Continuous synthesis method of 2-chloro-4-amino-5-methylpyridine 福建桦智工程技术有限公司 2026-04-24 CN disclosed
US-20260078122-A1 INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2026-03-19 US disclosed
US-20050234059-A1 Heterocyclic inhibitors of ERK2 and uses thereof VERTEX PHARMACEUTICALS INCORPORATED 2005-10-20 US disclosed
EP-1506189-A1 PYRROLE DERIVATIVES AS INHIBITORS OF ERK2 AND USES THEREOF Vertex Pharmaceuticals Incorporated (US) 2005-02-16 EP disclosed
US-20040029857-A1 Heterocyclic inhibitors of ERK2 and uses thereof VERTEX PHARMACEUTICALS INCORPORATED 2004-02-12 US disclosed
WO-2003091246-A1 PYRROLE DERIVATIVES AS INHIBITORS OF ERK2 AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-11-06 WO disclosed
CN-1311185-A Method for preparing 4-amino pyridine and its derivatives XINHUA PHARMACEUTICAL CO LTD S (CN) 2001-09-05 CN disclosed